MentionFox
Home › Executive changes › KALA BIO, Inc.
Leadership changes · KALA · SEC Form 8-K, Item 5.02

Leadership changes at KALA BIO, Inc. (2026)

Before you join, sell to or invest in KALA BIO, Inc.

MentionFox check on KALA BIO, Inc.: no red flags found in 6 sources; 1 item to note (checked 14 November 2026). mentionfox.com/c/executive-changes/kala-bio

  • Note: Layoff plan disclosed Oct 2025 (filing)

Check KALA BIO, Inc. before you join, sell or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about KALA BIO, Inc.?

Who joined and who left KALA BIO, Inc. (KALA)? 1 appointment and 2 departures reported from 2026-02-02 to 2026-02-20, each cited to the company's own filing.

Avi Minkowitz was named Chief Executive Officer and Chief Financial Officer of KALA BIO, Inc., succeeding David Lazar. As of November 14, 2026, KALA BIO, Inc. has reported 3 leadership change filings to the SEC under Item 5.02 of Form 8-K, from February 2, 2026 to February 20, 2026, naming 1 appointment and 2 departures (Form 8-K, February 5, 2026).

29 companies changed executives this week, 1 had other signals.

Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.

ONITY GROUP INC.announced the departure of its Chief Investment Officer
Adicet Bio, Inc.announced the departure of its Director
MAMMOTH ENERGY SERVICES, INC.announced the departure of its Chief Operating Officer
CERENOME, INC.named a new Director
Cohen & Co Inc.named a new Chief Executive Officer
Check one company free All companies that changed executives this week

SR One Capital Fund II Aggregator, LP also filed stake reports on 6 other companies ↓

Sell to companies like KALA BIO, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

Key facts

  • · In / out: Out · Person: David Lazar · Role: Director · 8-K, 2026-02-20
  • · In / out: Out · Person: David Lazar · Role: Chief Executive Officer and Chief Financial Officer · 8-K, 2026-02-05
  • · In / out: Reported · Person: not named in the filing · 8-K, 2026-02-02
Changes4
In (appointed)1
Out (departing)2
Latest filing2026-02-20

KALA BIO, Inc. reported changes in 3 filings among its directors and officers to the SEC on Form 8-K, Item 5.02, from 2026-02-02 to 2026-02-20. They name 2 people, with 1 appointment and 2 departures. Every row below is cited to the filing it comes from, and this page adds each new change as KALA BIO, Inc. files it.

Layoffs on record: about 19 jobs, latest 2025-10-20 (layoff filings and notices).

Also on the record for KALA BIO, Inc.

DateRecordFigureOur pageSource
October 19, 2026Stake report, Schedule 13G, by Labkowski Nachum5% of the class5%+ stakesSource
July 2, 2026Stake report, Schedule 13D/A, by Lazar David E.3.9% of the class5%+ stakesSource
May 15, 2026Stake report, Schedule 13G/A, by Baker Bros. Advisors LP0.01% of the class5%+ stakesSource
March 17, 2026Form D, private offering$1.75M soldForm D pageSource
February 17, 2026Stake report, Schedule 13G/A, by Baker Bros. Advisors LP9.99% of the class5%+ stakesSource
February 13, 2026Form D, private offering$2.25M soldForm D pageSource
February 6, 2026Stake report, Schedule 13D, by David E. Lazar5.18% of the class5%+ stakesSource
January 13, 2026Stake report, Schedule 13G, by LifeSci Capital LLC7.9% of the class5%+ stakesSource
December 3, 2025Stake report, Schedule 13G, by OXFORD FINANCE LLC16.5% of the class5%+ stakesSource
November 14, 2025Stake report, Schedule 13G/A, by Cormorant Asset Management, LP—5%+ stakesSource
November 14, 2025Stake report, Schedule 13G/A, by Perceptive Advisors LLC—5%+ stakesSource
November 14, 2025Stake report, Schedule 13G/A, by Point72 Asset Management, L.P.—5%+ stakesSource

Selling to them or working with them? See who runs KALA BIO, Inc. now and the warning signs.

Free to see. No signup.

Keep reading

More on KALA BIO, Inc. and the records around it.

KALA BIO, Inc. elsewhere on the record

Companies that share a holder

Want the whole picture on KALA BIO, Inc.?

Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News

A Full Report on KALA BIO, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on KALA BIO, Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    16 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The newest 12 of 19 records.

Timeline

FiledIn / outPersonRoleEffectiveSource
2026-02-20OutDirector8-K, 2026-02-20
2026-02-05OutChief Executive Officer and Chief Financial Officer8-K, 2026-02-05
2026-02-05InChief Executive Officer and Chief Financial Officer8-K, 2026-02-05
2026-02-02Reportednot named in the filing8-K, 2026-02-02

Why did they leave? What the filings say

KALA BIO, Inc.'s filings state no reason for the departures below. Where a filing gives none, it says so here; nothing is inferred.

Who leads KALA BIO, Inc., as last reported?

For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.

Selling to KALA BIO, Inc.?

New leaders reset buying decisions — get the Full Report on KALA BIO, Inc.: who runs it, how the money works and what to watch, every claim linked to its source.

Get the Full Report

Watch KALA BIO, Inc. (free up to 3)

Hiring for a seat like this?

Find people with the same kind of experience as the Director at KALA BIO, Inc., with the record behind each one.

Find candidates like Director at KALA BIO, Inc.

Every change, in the filing's words

Filed 2026-02-20 · 8-K

Departing: David Lazar, Director

On February 16, 2026, David Lazar notified KALA BIO, Inc. (the " Company ") of his decision to resign as a member of the Board of Directors of the Company, effective as of the same date.

Also stated in this filing

  • Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.
Filed 2026-02-05 · 8-K

Departing: David Lazar, Chief Executive Officer and Chief Financial Officer

On February 2, 2026, David Lazar tendered his resignation to the Board of the Directors (the " Board ") as the Chief Executive Officer and Chief Financial Officer of KALA BIO, Inc. (the " Company "), effective as of the same date.

Appointed: Avi Minkowitz, Chief Executive Officer and Chief Financial Officer

On February 2, 2026, to fill the executive vacancy as a result of Mr. Lazar's resignation as the Chief Executive Officer and Chief Financial Officer of the Company, the Board appointed Avi Minkowitz, a current director of the Company, as the Company's Chief Executive Officer and Chief Financial Officer, effective as of the same date.

Also stated in this filing

  • Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.
  • Mr. Lazar remains a director of the Board.
  • Prior to his appointment as the Company's Chief Executive Officer and Chief Financial Officer, Mr. Minkowitz served as Vice President at Parkit Enterprise Inc. (TSX: PKT.V), now an industrial real estate platform, from July 2018 to December 2020.
  • In that capacity, he sourced and underwrote potential real estate acquisitions for the Company.
  • His tenure ended with the successful underwriting and merger with an industrial real estate entity.
  • He subsequently served as an Analyst at Leonite Capital, a family office investment firm, from January 2021 to October 2024, where he focused primarily on financing for publicly traded companies, M&A, and business development.
  • In addition, since 2023, he has worked as a Management Consultant, advising companies on growth, restructuring, and financing.
  • Mr. Minkowitz currently serves on the board of directors at NuRAN Wireless Inc. (CSE: NUR) beginning in November 2025, and of International Star Inc. (OTC: ILST) beginning in October 2022.
Filed 2026-02-02 · 8-K

Reported

Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.

Also stated in this filing

  • Each of Messrs. Farid, Koven, Iwicki, Bazemore, Meyers and Rosen's resignations was due to the approval of the Issuance Proposal and the Share Increase Proposal at the Annual Meeting and did not arise or result from any disagreement with the Company on any matters relating to the Company's operations, policies or practices.

Tools for this story

Each opens in a new tab, filled in for KALA BIO, Inc.. With no account yet, you sign up free and land on the result.

Where this comes from

A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.

Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.

Not for employment, credit or tenancy decisions. MentionFox research is for sales, partnership and investor research. Permitted use

Cite this page

Permanent URL: https://mentionfox.com/executive-changes/kala-bio
Last updated 2026-11-14
Primary record: SEC filing 1 · SEC filing 2 · SEC filing 3 · SEC filing 4
KALA BIO, Inc. executive departures 2026. MentionFox, 2026-11-14. https://mentionfox.com/executive-changes/kala-bio